This PDF is the current document as it appeared on Public Inspection on 02/23/2015 at 08:45 am.
Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meeting.
The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Center for Complementary and Integrative Health Special Emphasis Panel, Center of Excellence for Natural Product Drug Interaction Research (U54).
Date: March 19-20, 2015.
Time: 8:00 a.m. to 1:00 p.m.
Agenda: To review and evaluate cooperative agreement applications.
Place: Residence Inn Bethesda, 7335 Wisconsin Avenue, Bethesda, MD 20814.
Contact Person: Peter Kozel, Ph.D., Scientific Review Officer, Nat Ctr for Complementary and Integrative Health, 6707 Democracy Blvd., Suite 401, Bethesda, MD 20892-5475, 301-496-8004, firstname.lastname@example.org.Start Printed Page 9740
(Catalogue of Federal Domestic Assistance Program Nos. 93.213, Research and Training in Complementary and Alternative Medicine, National Institutes of Health, HHS)Start Signature
Dated: February 18, 2015.
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2015-03632 Filed 2-23-15; 8:45 am]
BILLING CODE 4140-01-P